Multi-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay
Tracking the Immune Response of Patients Hospitalized with COVID-19 in 10 Research Sites Across the United StatesStudy May Inform Recommendations […]